Well I think VGH's results were really in line with expectations.
refractive continues to disappoint, but the non-discretionary side is really the heart of the operation, and that seems to be tracking well.
I must admit I was surprised to here that organic growth in opthalmology may be limited going forward, hence they are exploring other specialities such as plastics. I'm not sure I can see too many similarities between plastics and opthalmology, so VGH will remain in the "tradeable" mental file for the next little while.
VGH Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
